Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages

被引:19
|
作者
May, Theodor W. [1 ]
Helmer, Renate [1 ]
Bien, Christian G. [2 ]
Brandt, Christian [2 ]
机构
[1] Mara Hosp, Soc Epilepsy Res, Bielefeld, Germany
[2] Mara Hosp, Bethel Epilepsy Ctr, Bielefeld, Germany
关键词
lacosamide; antiepileptic drugs; drug interactions; age; therapeutic drug monitoring; NO PHARMACOKINETIC INTERACTION; TOTAL-BODY WATER; VALPROIC ACID; ADULTS; METHSUXIMIDE; CHILDREN;
D O I
10.1097/FTD.0000000000000538
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Lacosamide (LCM) is a new antiepileptic drug (AED). The purpose of the study was to investigate the effects of LCM dose, body weight, height, sex, age, and concomitant AEDs on LCM trough serum concentrations (at a steady state) in patients with epilepsy. Methods: A total number of 3154 blood samples of 973 consecutive patients of the Mara Hospital (Bethel Epilepsy Centre) were evaluated. Generalized estimating equation (GEE) models were used for statistical analyses. Results: GEE analyses showed that LCM trough serum concentrations were significantly correlated with the body weight-normalized LCM dose (range: 0.44-25.7 mg/kg; 45-1050 mg) and significantly dependent on comedication and age. Compared with adults (18-60 years), the LCM trough serum concentrations of children aged 6-12 years and children younger than 6 years were significantly lower (-21% to -38%, respectively) and those of elderly patients (. 60 years) were significantly higher (+20%). Sex had no significant influence. Carbamazepine, phenytoin, primidone, phenobarbital, and methsuximide decreased LCM trough serum concentrations significantly by 30%, 32%, 34%, 39%, and 41%, respectively, whereas other AEDs (eg, oxcarbazepine, eslicarbazepine acetate, valproate) had no significant or only a minor impact (zonisamide) on LCM trough concentrations. In children, the effect of enzyme-inducing AEDs was more marked. Of note, the number of blood samples (n = 151) of patients younger than 12 (n = 78) was comparatively low. Alternative GEE models confirmed the effect of comedication, whereas the effect of age, especially in children, depended on adjustment of LCM dosage to body weight, body surface area, or approximated volume of distribution. Conclusions: In accordance with previous therapeutic drug monitoring studies, our results confirmed that enzyme inducers reduce the LCM trough serum concentrations by 30%-40%. In children, the effects of comedication are more pronounced but should be confirmed by further studies.
引用
收藏
页码:620 / 627
页数:8
相关论文
共 50 条
  • [41] Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy
    Zhao, Mingming
    Chen, Yanan
    Wang, Minglu
    Li, Guofei
    Zhao, Limei
    THERAPEUTIC DRUG MONITORING, 2020, 42 (05) : 760 - 765
  • [42] Which factors have an impact on levetiracetam serum concentrations? An analysis in 163 patients with epilepsy
    Bauer, J.
    Pfeiffer, C.
    Burr, W.
    NERVENARZT, 2010, 81 (04): : 391 - +
  • [43] Perampanel Serum Concentrations in Adults With Epilepsy: Effect of Dose, Age, Sex, and Concomitant Anti-Epileptic Drugs
    Patsalos, Philip N.
    Gougoulaki, Marilia
    Sander, Josemir W.
    THERAPEUTIC DRUG MONITORING, 2016, 38 (03) : 358 - 364
  • [44] Influence of Kidney Function on Serum Risperidone Concentrations in Patients Treated With Risperidone
    Gruender, Philipp
    Augustin, Marc
    Paulzen, Michael
    Gruender, Gerhard
    JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (06) : E1 - E5
  • [45] Factors Influencing Sodium Valproate Serum Concentrations in Patients with Epilepsy Based on Logistic Regression Analysis
    Lan, Xiaobu
    Mo, Kai
    Nong, Li
    He, Yi
    Sun, Yuhong
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [46] Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy
    Suemaru, K
    Kawasaki, H
    Yasuhara, K
    Yao, K
    Furuno, K
    Kawakami, Y
    Araki, H
    Gomita, Y
    Oka, E
    ACTA MEDICA OKAYAMA, 1998, 52 (03) : 139 - 142
  • [47] POSTMORTEM SERUM-PROTEIN BINDING AND BRAIN CONCENTRATIONS OF ANTIEPILEPTIC DRUGS IN AUTOPTIC SPECIMENS FROM 45 EPILEPTIC PATIENTS
    RAMBECK, B
    SCHNABEL, R
    MAY, T
    JURGENS, U
    VILLAGRAN, R
    THERAPEUTIC DRUG MONITORING, 1990, 12 (06) : 533 - 540
  • [48] INFLUENCE OF SEX, AGE, WEIGHT, AND CARBAMAZEPINE DOSE ON SERUM CONCENTRATIONS, CONCENTRATION RATIOS, AND LEVEL/DOSE RATIOS OF CARBAMAZEPINE AND ITS METABOLITES
    LIU, H
    DELGADO, MR
    THERAPEUTIC DRUG MONITORING, 1994, 16 (05) : 469 - 476
  • [49] A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy
    Manna, Ida
    Gambardella, Antonio
    Bianchi, Amedeo
    Striano, Pasquale
    Tozzi, Rossana
    Aguglia, Umberto
    Beccaria, Francesca
    Benna, Paolo
    Campostrini, Roberto
    Canevini, Maria P.
    Condino, Francesca
    Durisotti, Christine
    Elia, Maurizio
    Giallonardo, Anna T.
    Iudice, Alfonso
    Labate, Angelo
    La Neve, Angela
    Michelucci, Roberto
    Muscas, Gian C.
    Paravidino, Roberta
    Zaccara, Gaetano
    Zucca, Claudio
    Zara, Federico
    Perucca, Emilio
    EPILEPSIA, 2011, 52 (05) : E40 - E44
  • [50] Predicted serum valproic acid concentrations in patients missing and replacing a dose of extended-release divalproex sodium
    Reed, RC
    Dutta, S
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (21) : 2284 - 2289